Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group

Stuart Hinton, Paul Catalano, Lawrence H. Einhorn, Patrick J. Loehrer, Timothy Kuzel, David Vaughn, George Wilding

Research output: Contribution to journalArticlepeer-review

124 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences